ID
45470
Beschrijving
Principal Investigator: Jay Shendure, PhD, University of Washington, Seattle, WA, USA MeSH: https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000500 The overall purpose of this study was to demonstrate the feasibility of producing haplotype-phased whole genome sequence data from a fetus using free fetal DNA isolated from maternal plasma collected during the first half of gestation.
Link
Trefwoorden
Versies (2)
- 02-11-22 02-11-22 - Tabea Kampen
- 13-12-22 13-12-22 - Kristina Keller
Houder van rechten
Jay Shendure, PhD, University of Washington, Seattle, WA, USA
Geüploaded op
13 december 2022
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
dbGaP phs000500 Non-Invasive Whole Genome Sequencing of a Human Fetus
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject ID aliases, and affection status.
- The pedigree data table contains pedigree and gender information of study participants. There are 2 family trios.
- The subject sample data table contains mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes a mapping of sample IDs to other sample ID aliases and sample use.
- The sample attributes data table includes body site where sample was extracted, sample analyte type and tumor status.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- The subject consent data table contains subject IDs, consent group information, subject ID aliases, and affection status.
- The pedigree data table contains pedigree and gender information of study participants. There are 2 family trios.
- The subject sample data table contains mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes a mapping of sample IDs to other sample ID aliases and sample use.
- The sample attributes data table includes body site where sample was extracted, sample analyte type and tumor status.
C1320396 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
C0086582 (UMLS CUI [1,4])
C0444245 (UMLS CUI [2,1])
C0015671 (UMLS CUI [2,2])
C0026591 (UMLS CUI [2,3])
C0008059 (UMLS CUI [3,1])
C0443281 (UMLS CUI [3,2])
C0444245 (UMLS CUI [3,3])